Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Neoplasms 1Dyspnea 1

Interventions

Cyclophosphamide 517Bevacizumab 487Carboplatin 424pembrolizumab 385Paclitaxel 385Gemcitabine 372Cisplatin 366Docetaxel 323Rituximab 316Radiotherapy 296Nivolumab 247Doxorubicin 243Dexamethasone 240Fluorouracil 225Capecitabine 214Oxaliplatin 211Erlotinib Hydrochloride 206fludarabine phosphate 201Etoposide 188Cetuximab 186Lenalidomide 177Pemetrexed 175Bortezomib 174Trastuzumab 173Filgrastim 171fludarabine 166Prednisone 166Leucovorin 166Cytarabine 166Irinotecan 161

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Has results × Respiratory Therapy × Clear all
NCT02357134 2022-12-07

High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With Cancer

M.D. Anderson Cancer Center

Phase 2 Unknown
74 enrolled 16 charts
Other

Dyspnea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡